Does ATORVASTATIN\EZETIMIBE Cause Product communication issue? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product communication issue have been filed in association with ATORVASTATIN\EZETIMIBE. This represents 0.4% of all adverse event reports for ATORVASTATIN\EZETIMIBE.
5
Reports of Product communication issue with ATORVASTATIN\EZETIMIBE
0.4%
of all ATORVASTATIN\EZETIMIBE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product communication issue From ATORVASTATIN\EZETIMIBE?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Product communication issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN\EZETIMIBE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN\EZETIMIBE Cause?
Myalgia (130)
Acute kidney injury (60)
Pain (45)
Pain in extremity (43)
Dizziness (42)
Malaise (42)
Pyrexia (41)
Rhabdomyolysis (40)
Arthralgia (39)
Headache (39)
What Other Drugs Cause Product communication issue?
EVOLOCUMAB (2,341)
SEMAGLUTIDE (842)
ERENUMAB-AOOE (598)
SOMATROPIN (350)
PEGFILGRASTIM (333)
ETANERCEPT (122)
ALBUTEROL (121)
NIRMATRELVIR\RITONAVIR (70)
DENOSUMAB (68)
LEVODOPA (61)
Which ATORVASTATIN\EZETIMIBE Alternatives Have Lower Product communication issue Risk?
ATORVASTATIN\EZETIMIBE vs ATOSIBAN
ATORVASTATIN\EZETIMIBE vs ATOVAQUONE
ATORVASTATIN\EZETIMIBE vs ATOVAQUONE\PROGUANIL
ATORVASTATIN\EZETIMIBE vs ATRACURIUM
ATORVASTATIN\EZETIMIBE vs ATRIPLA